Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_assertion type Assertion NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_head.
- NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_assertion description "[The role of TGF beta RII and BAX genes is limited as a target gene of MI+ phenotype in endometrial cancer, because several mutations of these genes were detected but a chromosomal loss was demonstrated by CGH in only one tumor in MI+ endometrial cancers with mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_provenance.
- NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_assertion evidence source_evidence_literature NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_provenance.
- NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_assertion SIO_000772 11585417 NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_provenance.
- NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_assertion wasDerivedFrom befree-2016 NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_provenance.
- NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_assertion wasGeneratedBy ECO_0000203 NP331817.RACzTLXrN7jIgCABbc0Cl3HgvDjhLvQ1znsS-VWPRyXrw130_provenance.